Fred Ramsdell
Fred Ramsdell | |
|---|---|
Ramsdell in 2025 at the U.S. Embassy Sweden Nobel laureate reception | |
| Born | Frederick Jay Ramsdell December 4, 1960 Elmhurst, Illinois, U.S. |
| Education | University of California, San Diego (BS) University of California, Los Angeles (PhD) |
| Awards | Crafoord Prize (2017) Nobel Prize in Physiology or Medicine (2025) |
| Scientific career | |
| Institutions | Parker Institute for Cancer Immunotherapy |
| Thesis | Generation of lymphokine-activated killer cells from non-natural killer cell sources: Development from human thymocytes (1988) |
| Academic advisors | Sidney Golub |
Frederick Jay Ramsdell (born December 4, 1960) is an American immunologist and Nobel Prize laureate. As of 2025, he is an advisor at Sonoma Biotherapeutics, a biotechnology company co-founded by him.
In 2025, he was jointly awarded the Nobel Prize in Physiology or Medicine with Mary E. Brunkow and Shimon Sakaguchi for their work in peripheral tolerance.